RA | AS | PsA | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | ||
Female sex | 1.40 | (0.16–12.54) | 0.765 | 0.52 | (0.16–1.68) | 0.276 | 0.64 | (0.30–1.33) | 0.241 | |
Age | 1.02 | (0.97–1.06) | 0.450 | 0.95 | (0.91–0.99) | 0.016 | 1.00 | (0.97–1.04) | 0.822 | |
TNF-i | 0.41 | (0.08–1.97) | 0.265 | - | - | - | - | - | - | |
Smoking (ref smoker) | Non-smoker | 2.53 | (0.29–22.19) | 0.401 | 0.34 | (0.09–1.22) | 0.099 | 1.66 | (0.57–5.08) | 0.371 |
Ex-smoker | 1.43 | (0.08–25.78) | 0.807 | 0.67 | (0.07–6.23) | 0.723 | ||||
Order of treatment | 3.74 | (0.95–14.71) | 0.06 | 0.84 | (0.25–2.74) | 0.767 | 1.53 | (0.69–3.42) | 0.298 | |
Disease duration | 0.98 | (0.90–1.07) | 0.649 | 0.94 | (0.86–1.04) | 0.228 | 0.99 | (0.93–1.05) | 0.778 | |
ACPA (ref negative) | Positive | 0.11 | (0.02–0.53) | 0.006 | - | - | - | - | - | - |
HLA B27 (ref negative) | Positive | - | - | - | 0.51 | (0.15–1.78) | 0.290 | 1.16 | (0.39–3.47) | 0.786 |
Time on treatment with the previous biologic agent | 1.03 | (1.02–1.05) | < 0.001 | 1.01 | (1.00–1.02) | 0.005 | ||||
Year of discontinuation of treatment | 0.88 | (0.73–1.06) | 0.178 | 0.90 | (0.80–1.02) | 0.11 | 0.99 | (0.90–1.08) | 0.787 |